Authors


Tony Guerra, PharmD

Latest:

How Mnemonics Can Help Students Ace the PCOA

Some pharmacy schools now use Pharmacy Curriculum Outcomes Assessment scores for academic probation.


Jeffrey S. Reichard, PharmD, MS, BCPS

Latest:

A System Approach to Pharmacy Leadership

Hospital acquisitions and mergers have become common in today's health care environment.


Craig M. Doane, MA

Latest:

Patient Adherence: Identifying Barriers and Defining Solutions

Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.


Joseph C. Cappelleri, PhD, MPH

Latest:

Therapeutic and Subtherapeutic Dosing of Pregabalin: Medication Adherence, Healthcare Resource Utilization, and Costs

Therapeutic and subtherapeutic doses of pregabalin were compared to ascertain differences in adherence, healthcare resource use, and cost between the cohorts.


Bradi L. Frei, PharmD, MS

Latest:

Cost of Squamous Cell Cancer of the Head and Neck

The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.


Ricky Newton, CPA

Latest:

Letter from Community Oncology Alliance

A letter to community oncology pharmacists from Ricky Newtown, CPA, director of Financial Services & Operations, Community Oncology Alliance.


Caroline Seymour

Latest:

USPSTF Updates Recommendation for Earlier Colorectal Cancer Screening

The United States Preventive Services Task Force updates recommends that colorectal cancer screening begin 5 years earlier, at age 45 instead of age 50.


funded by Eisai Inc.

Latest:

Trends in the 2012 Eisai Oncology Digest: Insurance and Cost Obstacles in Cancer Treatment

Results from Eisai Inc's online national survey of cancer patients, published in the 2012 Eisai Oncology Digest, highlight financial concerns of cancer treatment and their impact on treatment adherence.


Dan Leonard, President, National Pharmaceutical Council

Latest:

Going Beyond the Headlines on Health Spending in 4 Steps

Health care spending in the United States is at the center of a loud, fractured debate mired in deep complexity.


Anthony Bianchini

Latest:

Billions of Dollars and More Than a Decade Later, Now What?

The global launch of a new drug requires careful orchestration of sales and marketing support activities—a challenge that can have a large financial impact.


Nour Awad, BScPharm, Amjad Abuirmeileh, BScPharm, MSc, PhD

Latest:

The King Hussein Cancer Center in Jordan: Evolution of the Pharmacy Department

The pharmacy at KHCC has transformed itself into one of the leading health care providers in the Middle East.




Jonathan Greenberg, BS

Latest:

Patient Preference for Treatment Administration in Cystic Fibrosis

This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.


Jared C. Sheneman, PharmD candidate

Latest:

5 Ways Pharmacy Students Can Help During Pandemic

There is a number of things that pharmacy students can do to help their communities during the COVID-19 pandemic.


Erica Slaughter

Latest:

Sephin1 Therapy Could Be Effective Therapy for Multiple Sclerosis

Sephin1 found to protect oligodendrocytes, axons, and myelin, as well as reduce central nervous system inflammation in multiple sclerosis.


Corinn Martineau, PharmD, BCACP, CDOE

Latest:

Emphasize Medication Adherence to Patients

Methods Include Bioingestible Sensors, Motivational Interviewing, Packaging and Reminder Technology, and Synchronization


Katie Eder, Pharmacy Times

Latest:

FDA to Require Overdose Death Warnings on Opioid Labels

Label change is part an effort to help inform proviers about balancing the serious risks of opioids with their role in pain management.


Katie S. Doong, BS

Latest:

Community Pharmacist Involvement in Prescription Drug Monitoring Programs

The involvement of community pharmacists is vital to reduce prescription drug abuse through the use of Electronic Prescription Drug Monitoring Programs.


Cynthia Martens, PharmD

Latest:

Misinformation from the Drug Industry

The 340B program helps rural and urban safety-net health providers care for underserved patients across America every day.




Rebecca R. Boehman

Latest:

Combating Advancing Cancers With CAR T-Cell Therapy

Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.


Steven M. Schwartz, PhD

Latest:

Viability of a Dose Optimization Program Within a Specialty Pharmacy

Dose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.


Kyle Copeland, PharmD

Latest:

Learning to Breathe: Optimizing Management of COPD Based on Device Selection

A review of current treatment recommendations for chronic obstructive pulmonary disease with a focus on currently available medication devices.


Suzanne J. Francart, PharmD, BCPS, CPP

Latest:

Managing Rheumatoid Arthritis

A guide to treatment of rheumatoid arthritis, the most common chronic inflammatory joint disease.



Sayyem Akbar, PharmD, PhC, LT

Latest:

Flash Continuous Glucose Monitoring Utilization in Type 2 Diabetes

Continuous glucose monitoring has revolutionized the way patients with diabetes can monitor their glucose.


Yvette C. Terrie, BSPharm, RPh

Latest:

Understand the Basics of Immune-Enhancing Supplements

Data indicate potential benefits and risks with nutritional supplement use, highlighting the need for pharmacist counseling.


Benjamin Slen, MBA

Latest:

Infused Therapies: Cost Savings Benefits Through Home Infusion

Transitioning infusion therapy patients from hospital outpatient or medical office settings to home care, when appropriate, can result in significant reductions in medical drug spending.